Human trials of OpRegen from Israeli biotech Cell Cure (see here) at Hadassah Medical Center are proceeding well.  This unique stem cell therapy aims to stop progression of the dry form of Age-Related Macular Degeneration (AMD) that leads to blindness. … Continue reading →

Israel’s Cell Cure Neurosciences has been awarded a grant of NIS 6.1 million from the Office of the Chief Scientist. The grant will help finance the human clinical trials in 2014 of OpRegen, a cell-based therapeutic product for the treatment … Continue reading →

Israel’s Chief Scientist has awarded biotech Cell Cure Neurosciences a $1.5 million grant to help develop their cell-based OpRegen treatment for macular degeneration. The dry form of age-related macular degeneration is estimated to afflict over 7.3 million people in the … Continue reading →

Hadassah University medical scientists have produced stem cells that are not contaminated with animal components. They are already being used by Cell Cure Neurosciences to develop a treatment for age-related macular degeneration (AMD). http://www.jpost.com/Health/Article.aspx?id=275219